Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BVMF/B1MR34 stock hub

BVMF/B1MR34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/B1MR34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

51.2B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/B1MR34

In the news

Latest news · BVMF/B1MR34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.3

P25 11.3P50 14.6P75 19.6

Trailing P/E36.5

P25 15.2P50 21.5P75 27.3

ROE4.5

P25 5.3P50 12.3P75 22.5

ROIC7.4

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/B1MR34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	3,221
Employees Change	181%
Employees Change Percent	5.95
Enterprise value	BRL 47.3B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	BRL 51.2B
Price	BRL 132
Price currency	BRL
Rev Per Employee	5,251,248.35x
Sector	Healthcare
Sic	2836
Symbol	bvmf/B1MR34
Website	https://www.biomarin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.74%
EV Earnings	33.77x
EV/EBIT	17.11x
EV/EBITDA	15.06x
EV/FCF	11.83x
EV/Sales	2.98x
FCF yield	7.82%
Forward P/E	9.29x
P/B ratio	1.58x
P/E ratio	36.5x
P/S ratio	3.03x
PE Ratio3 Y	60.93x
PE Ratio5 Y	150.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.42%
EBITDA Margin	19.47%
FCF margin	23.66%
Gross margin	51.16%
Gross Profit	BRL 8.7B
Gross Profit Growth	0.97%
Gross Profit Growth Q	-9.76%
Gross Profit Growth3 Y	17.97%
Gross Profit Growth5 Y	19.64%
Net Income	BRL 1.4B
Net Income Growth	-48.7%
Net Income Growth Q	-43.17%
Net Income Growth3 Y	55.4%
Net Income Growth5 Y	-19.5%
Pretax Margin	11.89%
Profit Margin	8.29%
Profit Per Employee	BRL 435,254
ROA	4.49
Roa5y	2.28
ROCE	7.24
ROE	4.48
Roe5y	3.83
ROIC	7.43
Roic5y	3.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-22.54%
Cagr3y	-17.59%
Cagr5y	-8.25%
EPS Growth	-48.33
EPS Growth Q	-43.42
EPS Growth3 Y	55.68
EPS Growth5 Y	-19.74
FCF Growth	22.89%
FCF Growth Q	26.71%
FCF Growth3 Y	192.02%
FCF Growth5 Y	46.21%
OCF Growth	24.85%
OCF Growth Q	26.52%
OCF Growth3 Y	81.01%
OCF Growth5 Y	32.5%
Revenue Growth	9.9x
Revenue Growth Q	2.83x
Revenue Growth3 Y	14.27x
Revenue Growth5 Y	11.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.41
Assets	BRL 44.8B
Cash	BRL 11.6B
Current Assets	BRL 22.6B
Current Liabilities	BRL 3.9B
Debt	BRL 7.5B
Debt EBITDA	BRL 2.24
Debt Equity	BRL 0.23
Debt FCF	BRL 1.88
Equity	BRL 32.4B
Interest Coverage	24.56
Liabilities	BRL 12.4B
Long Term Assets	BRL 22.2B
Long Term Liabilities	BRL 8.5B
Net Cash	BRL 4.1B
Net Cash By Market Cap	BRL 7.98
Net Cash Growth	18.17%
Net Debt EBITDA	BRL -1.24
Net Debt Equity	BRL -0.13
Net Debt FCF	BRL -1.02
Tangible Book Value	BRL 30.3B
Tangible Book Value Per Share	BRL 157
WACC	4.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.81
Inventory Turnover	1.24
Net Working Capital	BRL 8.3B
Quick ratio	3.94
Working Capital	BRL 19.9B
Working Capital Turnover	BRL 5.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-22.53%
200-day SMA	187.8
3Y total return	-44.04%
50-day SMA	149.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-34.99%
All Time High	348.9
All Time High Change	-62.17%
All Time High Date	2020-07-20
All Time Low	131.1
All Time Low Change	0.69%
All Time Low Date	2026-05-06
ATR	4.83
Beta	0.23
Ch YTD	-20.99
High	132
High52	175
High52 Date	2025-05-12
High52ch	-27.7%
Low	132
Low52	131.1
Low52 Date	2026-05-06
Low52ch	0.69%
Ma50ch	-11.8%
Price vs 200-day SMA	-29.73%
RSI	33.05
RSI Monthly	38.31
RSI Weekly	36.73
Sharpe ratio	-0.64x
Sortino ratio	-0.81
Total Return	-0.86%
Tr YTD	-20.99
Tr1m	-15.92%
Tr1w	-2.11%
Tr3m	-11.94%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 2.9B
Operating Income Growth	-21.1
Operating Income Growth Q	-38.52
Operating Income Growth3 Y	78.02
Operating margin	17.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	192,153,823%
Net Borrowing	4,177,070,000
Shares Insiders	0.49%
Shares Institutions	97.9%
Shares Qo Q	2.83%
Shares Yo Y	0.86%
Short Ratio	4.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 3B
Average Volume	603.05x
Bv Per Share	167.7
CAPEX	BRL -559.2M
Ch1m	-15.92
Ch1w	-2.11
Ch1y	-22.53
Ch3m	-11.94
Ch3y	-44.04
Ch5y	-34.99
Ch6m	-5.17
Change	0.69%
Change From Open	0
Close	131.1
Days Gap	0.69
Depreciation Amortization	326,789,385.8
Dollar Volume	26,392
Earnings Date	2026-04-24
EBIT	BRL 2.9B
EBITDA	BRL 3.3B
EPS	BRL 7.29
F Score	5
FCF	BRL 4B
FCF EV Yield	8.45x
Financing CF	4,223,210,157
Fiscal Year End	December
Founded	1,996
Goodwill	964,161,125.8
Graham Number	82.4508
Graham Upside	-37.52
Income Tax	BRL 609.6M
Investing CF	1,771,203,339
Is Primary Listing	0
Last Earnings Date	2026-02-23
Last Report Date	2026-03-31
Lynch Fair Value	BRL 18.08
Lynch Upside	-86.3
Ma150	177.4
Ma150ch	-25.62%
Ma20	151.2
Ma20ch	-12.73%
Net CF	10,556,731,645
Open	132
P FCF Ratio	12.79
P OCF Ratio	11.22
Ppne	4,708,152,508.2
Price Date	2026-05-08
Price EBITDA	BRL 15.54
Ptbv Ratio	1.69
Relative Volume	0.33x
Revenue	16,914,270,935x
SBC By Revenue	5.77x
Share Based Comp	976,398,768
Tax By Revenue	3.6x
Tax Rate	30.3%
Tr6m	-5.17%
Volume	200
Z Score	3.94

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVMF/B1MR34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/B1MR34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/B1MR34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+97.9%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/B1MR34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.1

Neutral momentum band

Price vs 200-day MA

-29.7%

50/200-day relationship not available

Beta (5Y)

0.23

Less volatile than the market

Sharpe ratio

-0.64

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/B1MR34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/B1MR34 stock rating?

bvmf/B1MR34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/B1MR34 analysis?

The full report lives at /stocks/bvmf/B1MR34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/B1MR34?

The latest report frames bvmf/B1MR34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/B1MR34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.